The research relevance is determined by the limited information on the molecular mechanisms of fatty hepatosis development in mammals and the identification of effective markers for the diagnosis of this pathology. Timely diagnosis of fatty hepatosis is also relevant for the prevention of dangerous complications, primarily cirrhosis of the liver and hepatocellular carcinoma. Disorders in lipid metabolism are substantial in the pathogenesis of fatty hepatosis. Therefore, the study aimed to establish regular changes in the liver lipid profile in rats with artificially induced fatty hepatosis and the use of milk phospholipids as corrective therapy. For this purpose, thin-layer chromatography was used. The study determined that in the case of artificial reproduction of tetracycline hepatosis in the liver of rats, a deficient level of total lipid fractions is formed. The esterified cholesterol fraction undergoes particularly sharp changes, the content of which decreased by 51.3% compared to the control. Oral administration of a milk phospholipid-based dietary supplement to sick rats prevented disruption of the lipid composition of the liver, which may indicate sufficient efficiency of absorption of the dietary supplement’s phospholipids in the intestine and a stimulating effect of its components on their endogenous formation in hepatocytes. In addition, deficient levels of liver phospholipid spectrum indicators were observed in sick animals. A decrease in the total fraction of inositol phosphatide and phosphatidylinositol by 26.6%, phosphatidylserine by 19.9%, sphingomyelin by 18.2%, phosphatidylcholine by 18.3% and phosphatidylethanolamine by 19.6%, and the restoration of their parameters when milk phospholipids were administered to rats. When the dietary supplement was administered to clinically healthy rats, a significant increase in the liver content of all fractions of total lipids and individual phospholipids was observed. Based on the results obtained, it is reasonable to recommend the bioactive supplement “FLP-MD” as a corrective therapy for lipid metabolism disorders in cases of functional liver disorders in animals with fatty hepatosis
tetracycline hydrochloride; corrective therapy; thin-layer chromatography; lipid and phospholipid spectra; fatty dystrophy
[1] Arab, J.P., Arrese, M., & Trauner, M. (2018). Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Annual Review of Pathology, 13, 321-350. doi: 10.1146/annurev-pathol-020117-043617.
[2] Berardo, C., Di Pasqua, L.G., Cagna, M., Richelmi, P., Vairetti, M., & Ferrigno, A. (2020). Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research. International Journal of Molecular Sciences, 21(24), article number 9646. doi: 10.3390/ijms21249646.
[3] Blunsom, N.J., & Cockcroft, S. (2020). CDP-Diacylglycerol Synthases (CDS): Gateway to phosphatidylinositol and cardiolipin synthesis. Frontiers in Cell and Developmental Biology, 8, article number 63. doi: 10.3389/fcell.2020.00063.
[4] Chua, B.A., Ngo, J.A., Situ, K., & Morizono, K. (2019). Roles of phosphatidylserine exposed on the viral envelope and cell membrane in HIV-1 replication. Cell Communication and Signaling, 17, article number 132. doi: 10.1186/s12964-019-0452-1.
[5] Directive 2010/63/EU of the European Parliament and of the Council “On the Protection of Animals Used for Scientific Purposes”. (2010, September). Retrieved from https://eur-lex.europa.eu/eli/dir/2010/63/oj/eng.
[6] Dajani, A.I., & Popovic, B. (2020). Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis. World Journal of Clinical Cases, 8(21), 5235-5249. doi: 10.12998/wjcc.v8.i21.5235.
[7] Errico, S., et al. (2023). Quantitative attribution of the protective effects of aminosterols against protein aggregates to their chemical structures and ability to modulate biological membranes. Journal of Medicinal Chemistry, 66(14), 9519-9536. doi: 10.1021/acs.jmedchem.3c00182.
[8] European Convention for the Protection of Vertebrate Animals Used for Research and Other Scientific Purposes. (1986, March). Retrieved from https://zakon.rada.gov.ua/go/994_137.
[9] Rehfeld, J.F. (2025). Cholecystokinin: Clinical aspects of the new biology. Journal of Internal Medicine, 298(3), 251-267. doi: 10.1111/joim.20110.
[10] Feriod, C.N., et al. (2017). Hepatic inositol 1, 4, 5 trisphosphate receptor type 1 mediates fatty liver. Hepatology Communications, 1(1), 23-35. doi: 10.1002/hep4.1012.
[11] Filimonova, N.B., Fil, I.O., & Mykhailova, T.S. (2004). Statistical analysis of data according to the principles of science-based medicine. Comparison of groups in quantitative terms. Medicine of Ukrainian Transport, 4, 85-93.
[12] Frydrych, A., Kulita, K., Jurowski, K., & Piekoszewski, W. (2025). Lipids in clinical nutrition and health: Narrative review and dietary recommendations. Foods, 14(3), article number 473. doi: 10.3390/foods14030473.
[13] Garcia, C., Andersen, C.J., & Blesso, C.N. (2023). The role of lipids in the regulation of immune responses. Nutrients, 15(18), article number 3899. doi: 10.3390/nu15183899.
[14] Gryshchenko, V.A., Danchenko, O.О., Tkachuk, S.A., Fotina, T.I., Zazharskyi, V.V., & Brygadyrenko, V.V. (2023). Lipid composition of blood plasma and epithelium of the jejunal mucosa in calves with dyspepsia and its correction. Regulatory Mechanisms in Biosystems, 14(2), 319-324. doi: 10.15421/022347.
[15] Kates, M. (1986). Techniques in lipidology: Isolation analysis and identification of lipids (2nd ed.). Amsterdam: Elsevier Press.
[16] Kovalchuk, I.I., Pylypets, A.Z., Prodanchuk, O.V., Tsap, M.M., Lesyk, Y.V., & Kolotnytskyi, V.A. (2025). Effect of selenium citrate on the lipid and phospholipid composition of rabbit blood plasma. Fiziologichnyi Zhurnal, 71(2), 58-66. doi: 10.15407/fz71.02.058.
[17] Law of Ukraine No. 3447-IV “On the Protection of Animals from Cruelty”. (2006, February). Retrieved from https://zakon.rada.gov.ua/laws/show/3447-15#Text.
[18] Lemos, F.O., Florentino, R.M., Lima Filho, A.C.M., Dos Santos, M.L., & Leite, M.F. (2019). Inositol 1,4,5-trisphosphate receptor in the liver: Expression and function. World Journal of Gastroenterology, 25(44), 6483-6494. doi: 10.3748/wjg.v25.i44.6483.
[19] Li, S., Tan, Y., Liu, S., & Li, C. (2025). Mitigating liver dysfunction and lipid accumulation: The role of chitosan self-assembled coconut meal fiber in high-fat diet-induced lipid metabolic disturbances. Food Bioscience, 69, article number 106945. doi: 10.1016/j.fbio.2025.106945.
[20] Lobasso, S., Lobaccaro, J.A., & Angelini, R. (2022). Editorial: The multifaceted roles of lipids in physiological and pathophysiological states. Frontiers in Physiology, 13, article number 930962. doi: 10.3389/fphys.2022.930962.
[21] Ma, X., Li, X., Wang, W., Zhang, M., Yang, B., & Miao, Z. (2022). Phosphatidylserine, inflammation, and central nervous system diseases. Frontiers in Aging Neuroscience, 14, article number 975176. doi: 10.3389/fnagi.2022.975176.
[22] Mao, J., Tan, L., Tian, C., Wang, W., Zhang, H., Zhu, Z., & Li, Y. (2024). Research progress on rodent models and its mechanisms of liver injury. Life Sciences, 337, article number 122343. doi: 10.1016/j.lfs.2023.122343.
[23] Martin-Grau, M., & Monleon, D. (2023). Sex dimorphism and metabolic profiles in management of metabolic-associated fatty liver disease. World Journal of Clinical Cases, 11(6), 1236-1244. doi: 10.12998/wjcc.v11.i6.1236.
[24] Melnychuk, D.O., & Hryshchenko, V.A. (2014). Exchange of bile pigments under the action of ecopathogenic factors on organism. The Ukrainian Biochemical Journal, 86(5), article number 156.
[25] Mousavi, T. (2023). The fascinating world of lipids: functions and types. Research & Reviews: Research Journal of Biology, 11, article number 002. doi: 10.4172/2322-0066.11.5.002.
[26] Murata, M., Satake, M., & Matsumori, N. (2025). Conformational dynamics and molecular interactions of natural products: Unveiling functional structures in biological membranes. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 101(5), 249-273. doi: 10.2183/pjab.101.016.
[27] Nikolajevic, N., Nikolajevic, M., Pantic, I., Korica, B., Kotseva, M., Alempijevic, T., Jevtic, D., Madrid, C.I., & Dumic, I. (2024). Drug-induced liver injury due to doxycycline: A case report and review of literature. Cureus, 16(5), article number e59687. doi: 10.7759/cureus.59687.
[28] Parton, R.G., & Simons, K. (2024). The biology of lipids. Cold Spring Harbor Perspectives in Biology, 16(8), article number a041713. doi: 10.1101/cshperspect.a041713.
[29] Pydyn, N., Miękus, K., Jura, J., & Kotlinowski, J. (2020). New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis. Pharmacological Reports, 72(1), 1-12. doi: 10.1007/s43440-019-00020-1.
[30] Sessa, L., Nardiello, A.M., Santoro, J., Concilio, S., & Piotto, S. (2021). Hydroxylated fatty acids: The role of the sphingomyelin synthase and the origin of selectivity. Membranes, 11(10), article number 787. doi: 10.3390/membranes11100787.
[31] Shyu, P., Ng, B.S.H., Ho, N., Chaw, R., Seah, Y.L., Marvalim, C., & Thibault, G. (2019). Membrane phospholipid alteration causes chronic ER stress through early degradation of homeostatic ER-resident proteins. Scientific Reports, 9(1), article number 8637. doi: 10.1038/s41598-019-45020-6.
[32] Stein, O., & Stein, Y. (2005). Lipid transfer proteins (LTP) and atherosclerosis. Atherosclerosis, 178(2), 217-230. doi: 10.1016/j.atherosclerosis.2004.10.008.
[33] Tan, S.T., Ramesh, T., Toh, X.R., & Nguyen, L.N. (2020). Emerging roles of lysophospholipids in health and disease. Progress in Lipid Research, 80, article number 101068. doi: 10.1016/j.plipres.2020.101068.
[34] Thakur, S., Kumar, V., Das, R., Sharma, V., & Mehta, D.K. (2024). Biomarkers of hepatic toxicity: An overview. Current Therapeutic Research, Clinical and Experimental, 100, article number 100737. doi: 10.1016/j.curtheres.2024.100737.
[35] Vaskovsky, V.E., Kostetsky, E.Y., & Vasendin, I.M. (1975). A universal reagent for phospholipid analysis. Journal of Chromatography, 114(1), 129-141. doi: 10.1016/s0021-9673(00)85249-8.
[36] Veselskyi, S., Liaschenko, P., Kostenko, S., Horenko, Z., & Kurovska, L. (2001). The method of preparing samples of biofluids for determining the content of substances of a lipid nature. (Patent of Ukraine No. 33564). Retrieved from https://sis.nipo.gov.ua/uk/search/detail/342563/.
[37] Zhang, J., Zang, X., Lv, J., Zhang, Y., Lv, Z., & Yu, M. (2023). Changes in lipidomics, metabolomics, and the gut microbiota in CDAA-induced NAFLD mice after polyene phosphatidylcholine treatment. International Journal of Molecular Sciences, 24(2), article number 1502. doi: 10.3390/ijms24021502.
[38] Zhou, Y., Dai, Z., Deng, K., Wang, Y., Ying, J., Chu, D., Zhou, J., & Tang, C. (2023). Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics. Journal of Pharmaceutical Analysis, 13(9), 1058-1069. doi: 10.1016/j.jpha.2023.05.012.